Mike Madigan trial: Defense cross-examines star witness in former IL speaker trial

Trial expected to last months

WLS logo
Last updated: Thursday, November 14, 2024 3:19PM GMT
Star witness back on stand for 5th day in Madigan trial
The defense continues to cross-examine a star witness on Wednesday in Michael Madigan's federal corruption trial.

CHICAGO (WLS) -- The corruption trial for former Illinois House Speaker Michael Madigan has begun.

Madigan had been indicted on federal racketeering and bribery charges as a part of what federal prosecutors call "the Madigan enterprise," where they say he allegedly committed crimes for his personal gain and that of his political allies.

The blockbuster trial is expected to take several months.

Check back with ABC7 Chicago for live updates.

WLS logo
3:23 PM GMT

What to expect from months-long Madigan trial

Jury selection will begin this week in the corruption trial of former Illinois House Speaker Michael Madigan, whose half-century career and status as Illinois' most powerful politician ended nearly four years ago as the feds circled ever-closer to his inner circle.

Madigan was once considered the most powerful politician in Illinois, serving as House speaker for a total of 36 years. The 82-year-old ex-speaker faces bribery and racketeering charges - along with his longtime friend and powerful Springfield lobbyist Mike McClain - in a case that frames Madigan's power in government, politics and as a partner in his law firm as a criminal enterprise.

Jury selection begins this week in the corruption trial of former Illinois House Speaker Michael Madigan.

The trial, which is scheduled to last through mid-December, is the culmination of more than a decade of digging by the FBI and prosecutors, and it's the final in a series of related cases that have played out in Chicago's federal courthouse over the last few years.

Opening statements in the case are likely to begin on Tuesday, Oct. 15, though Blakey this week said jury selection should take as long as it needs. The trial is scheduled through Dec. 13.